Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Head of Department Professor Andrew Carr has received the Arthur Steindler Award at this year’s Orthopaedic Research Association Annual Meeting.

The Arthur Steindler Award is given every other year to recognise an outstanding global contribution to orthopaedic research. The Award distinguishes "senior scientists, clinicians and educators who, throughout their professional lifetime, have made significant contributions - nationally and internationally - to the understanding of the musculoskeletal system and musculoskeletal diseases and injuries."

An orthopaedic surgeon, Professor Andrew Carr's research group focuses on improving evidence for the effectiveness of surgery generally and translating new surgical techniques and implants into the clinic.

Arthur Steiner MD was an orthopaedic surgeon, scientist and teacher, acknowledged by his peers as a pioneer in clinical and research advances in orthopaedic surgery and rehabilitation, having been instrumental in the passage of two Iowa laws that significantly altered the state's health care landscape. His research studies and medical textbooks were widely published and used by generations of medical students and residents in the US.

Similar stories

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Patients like me

What can patients learn from the experiences of people like them who’ve already had a hip replacement? A new tool called ‘Patients like me’ helps answer some of the questions about pain, complications and how long the prosthesis might last.

Study reveals new evidence on rare blood-clotting condition after covid-19 vaccination

Researchers from NDORMS at the University of Oxford have investigated claims that some adenovirus-based COVID-19 vaccines increase the risk of rare blood clots compared to their mRNA-based counterparts.

NDORMS contributes to new UK research to tackle monkeypox outbreak

The UK’s efforts to tackle the monkeypox outbreak will receive a huge boost with the creation of a new research consortium and a new study to study vaccine effectiveness.

World Osteoporosis Day 2022

A bone-healthy lifestyle is vital for strong bones and a mobile, fracture-free future. On World Osteoporosis Day, we are sharing advice from the International Osteoporosis Foundation (IOF), on putting your bone health first.

Mathematician boosts data science research at the Kennedy Institute

Welcome to Yang Luo who has joined the Kennedy Institute as the Principal Investigator of the Luo Group. Her lab is leading the investigation into how genetic variations contribute to diseases of the immune system.